AAp-MSMD: Amino Acid Preference Mapping on Protein–Protein Interaction Surfaces Using Mixed-Solvent Molecular Dynamics DOI Creative Commons
Genki Kudo, Keisuke Yanagisawa, Ryunosuke Yoshino

и другие.

Journal of Chemical Information and Modeling, Год журнала: 2023, Номер 63(24), С. 7768 - 7777

Опубликована: Дек. 12, 2023

Peptides have attracted much attention recently owing to their well-balanced properties as drugs against protein–protein interaction (PPI) surfaces. Molecular simulation-based predictions of binding sites and amino acid residues with high affinity PPI surfaces are expected accelerate the design peptide drugs. Mixed-solvent molecular dynamics (MSMD), which adds probe molecules or fragments functional groups solutes hydration model, detects hotspots cryptic induced by small molecules. The detection results vary depending on type molecule; thus, they provide important information for drug design. For rational using MSMD, we proposed MSMD residue probes, named probe-based (AAp-MSMD), detect identify favorable types protein bind. We assessed our method in terms hotspot at level free energy prediction probes site complex structure that formed PPI. In detection, max-spatial probability distribution map (max-PMAP) obtained from AAp-MSMD detected site, each can bind favorably. ΔGFE roughly estimated experimental affinities structure–activity relationship. AAp-MSMD, provides a target protein.

Язык: Английский

Annual review of PROTAC degraders as anticancer agents in 2022 DOI
Xiao Wang,

Zhao-Long Qin,

Na Li

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 267, С. 116166 - 116166

Опубликована: Янв. 25, 2024

Язык: Английский

Процитировано

57

Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds DOI Creative Commons
Aleksandra Leśniewska, Piotr Przybylski

European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 275, С. 116556 - 116556

Опубликована: Июнь 5, 2024

Azepanes or azepines are structural motifs of many drugs, drug candidates and evaluated lead compounds. Even though compounds having N-heterocyclic 7-membered rings often found in nature (e.g. alkaloids), the natural this group rather rare as approved therapeutics. Thus, recently studied azepane azepine-congeners predominantly consist semi-synthetically synthetically-obtained scaffolds. In review a comparison drugs investigated leads was proposed taking into regard their aspects (stereochemistry), biological activities, pharmacokinetic properties confirmed molecular targets. The N-heterocycles reveal wide range not only against CNS diseases, but also e.g. antibacterial, anticancer, antiviral, antiparasitic allergy agents. As most potential structures, belonging to N-heterocycles, synthetic scaffolds, report reveals different efficient metal-free cascade approaches useful synthesize both simple azepine-containing congeners those oligocyclic structures. Stereochemistry azepane/azepine fused systems, view data binding with targets, is discussed. Apart from we compare advances SAR studies (mainly 2018 2023), whereas related part concerning various domino strategies focused on last ten years.

Язык: Английский

Процитировано

12

A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy DOI
Weixin Zhang, Jiao Huang,

Xin-Yi Tian

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2023, Номер 259, С. 115673 - 115673

Опубликована: Июль 20, 2023

Язык: Английский

Процитировано

22

New drug approvals for 2022: Synthesis and clinical applications DOI
Shuo Yuan, Dandan Shen, Rui Jia

и другие.

Medicinal Research Reviews, Год журнала: 2023, Номер 43(6), С. 2352 - 2391

Опубликована: Май 21, 2023

Abstract The U.S. Food and Drug Administration has approved a total of 37 new drugs in 2022, which are composed 20 chemical entities 17 biologics. In particular, entities, including small molecule drugs, 1 radiotherapy, 2 diagnostic agents, provide privileged scaffolds, breakthrough clinical benefits, mechanism action for the discovery more potent candidates. structure‐based drug development with clear targets fragment‐based scaffolds have always been important modules field discovery, could easily bypass patent protection bring about improved biological activity. Therefore, we summarized relevant valuable information application, action, synthesis newly 2022. We hope this timely comprehensive review creative elegant inspiration on synthetic methodologies novel extended indications.

Язык: Английский

Процитировано

18

Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities DOI
Bowen Wu, Wenjing Huang, Yunhe Liu

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 265, С. 116118 - 116118

Опубликована: Янв. 3, 2024

Язык: Английский

Процитировано

8

A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects DOI

Yi‐Ru Bai,

Dong‐Jie Seng,

Ying Xu

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2024, Номер 276, С. 116706 - 116706

Опубликована: Июль 22, 2024

Язык: Английский

Процитировано

7

Tubulin degradation: Principles, agents, and applications DOI
Yifan Zhang, Jiao Huang, Weixin Zhang

и другие.

Bioorganic Chemistry, Год журнала: 2023, Номер 139, С. 106684 - 106684

Опубликована: Июнь 21, 2023

Язык: Английский

Процитировано

15

Sulfone Electrophiles in Cross-Electrophile Coupling: Nickel-Catalyzed Difluoromethylation of Aryl Bromides DOI
K. Benjamin,

Samantha Gavin,

Benjamin N. Ahern

и другие.

ACS Catalysis, Год журнала: 2024, Номер 14(14), С. 11087 - 11100

Опубликована: Июль 9, 2024

Fluoroalkyl fragments have played a critical role in the design of pharmaceutical and agrochemical molecules recent years due to enhanced biological properties fluorinated compared their non-fluorinated analogues. Despite potential advantages conferred by incorporating difluoromethyl group organic compounds, industrial adoption difluoromethylation methods lags behind fluorination trifluoromethylation. This is part challenges applying common sources towards applications. We report here nickel-catalyzed cross-electrophile coupling (hetero)aryl bromides with 2-pyridyl sulfone, sustainably sourced, crystalline reagent. The scope this reaction demonstrated 24 examples (67 ± 16% average yield) including diverse array heteroaryl precursors difluoromethyl-containing preclinical pharmaceuticals. can be applied small-scale parallel synthesis benchtop scale-up under mild conditions. As sulfone reagents are uncommon electrophiles coupling, mechanism process was investigated. Studies confirmed formation •CF2H instead difluorocarbene. A series modified sulfones revealed that reactivity does not correlate exclusively reduction coordination cations or nickel pyridyl essential reactivity, setting out parameters for matching coupling.

Язык: Английский

Процитировано

6

Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities DOI
Yunhe Liu, Ziyue Wang, Yifei Du

и другие.

Bioorganic & Medicinal Chemistry, Год журнала: 2025, Номер unknown, С. 118109 - 118109

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Chronic kidney disease-associated pruritus and patient-centred outcomes: a systematic review DOI Creative Commons
Teng Wang, Jia Goh, Shrey Seth

и другие.

Journal of Nephrology, Год журнала: 2025, Номер unknown

Опубликована: Фев. 25, 2025

Abstract Background Chronic kidney disease-associated pruritus (CKD-aP) is a debilitating symptom that can significantly impact patients’ daily activities and quality of life. This systematic review aimed to assimilate the latest evidence on relationship between CKD-associated pruritis patient-centred outcomes. Methods A comprehensive search was conducted identify relevant studies in PubMed, Medline Embase via OVID, CINAHL, Web Science from 2000 June 2024. Quality appraisal subsequent data extraction were performed using Joanna Briggs Institute (JBI) tools modified form derived JBI. Results The included 29 with total 147,174 CKD patients, including those haemodialysis (HD) peritoneal dialysis (PD). most frequently reported outcomes life ( n = 21), sleep 17), anxiety/depression 11) mortality 7). There paucity patients pre-dialysis stages, undergoing PD, following conservative (non-dialytic) pathway. contingent severity pruritus. an association increased medication usage, decreased compliance HD treatments higher rates hospitalisation experiencing severe Conclusion Our underscores pernicious patient emphasises importance effective management improve Additional investigations are warranted among pathways, achieve more understanding these groups. Graphical abstract

Язык: Английский

Процитировано

0